CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 2 filers reported holding CYMABAY THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $3,136,949 | +1727.3% | 132,809 | +574.6% | 0.01% | +500.0% |
Q1 2023 | $171,671 | -70.3% | 19,687 | -78.6% | 0.00% | -66.7% |
Q4 2022 | $577,498 | +175.0% | 92,105 | +53.4% | 0.00% | +200.0% |
Q3 2022 | $210,000 | +288.9% | 60,024 | +230.5% | 0.00% | – |
Q2 2022 | $54,000 | -58.5% | 18,162 | -19.8% | 0.00% | -100.0% |
Q4 2020 | $130,000 | -71.3% | 22,658 | -63.8% | 0.00% | -66.7% |
Q3 2020 | $453,000 | +1158.3% | 62,577 | +514.5% | 0.01% | +500.0% |
Q2 2020 | $36,000 | – | 10,183 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 1,787,094 | $26,645,572 | 14.80% |
Lynx1 Capital Management LP | 994,161 | $14,822,941 | 9.80% |
Octagon Capital Advisors LP | 3,073,750 | $45,829,613 | 7.04% |
Saturn V Capital Management LP | 1,124,459 | $16,765,684 | 7.02% |
Altium Capital Management LP | 800,000 | $11,928,000 | 6.22% |
Affinity Asset Advisors, LLC | 1,129,376 | $16,838,996 | 4.74% |
ACUTA CAPITAL PARTNERS, LLC | 418,000 | $6,232,380 | 4.18% |
Cormorant Asset Management, LP | 3,850,000 | $57,403,500 | 3.35% |
SILVERARC CAPITAL MANAGEMENT, LLC | 590,000 | $8,796,900 | 2.67% |
MPM BioImpact LLC | 610,770 | $9,106,581 | 2.43% |